Join to view full profile
10 Center DrNih/Ninds/Nib Bld10/Rm5c103Bethesda, MD 20892
Phone+1 301-496-1801
Fax+1 301-402-0373
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bibiana Bielekova, MD is a board certified neurologist in Bethesda, Maryland. She is currently licensed to practice medicine in Maryland.
Education & Training
Boston University Medical CenterResidency, Neurology, 1994 - 1997
SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 1993 - 1994
Comenius UniversityClass of 1993
Certifications & Licensure
MD State Medical License 2009 - 2026
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 7 citationsMigration arrest and transendothelial trafficking of human pathogenic-like Th17 cells are mediated by differentially positioned chemokines.Farhat Parween, Satya P Singh, Nausheen Kathuria, Hongwei H Zhang, Shinji Ashida
Nature Communications. 2025-02-26 - Data-driven risk/benefit estimator for multiple sclerosis therapies.Bibiana Bielekova, Tianxia Wu, Peter Kosa, Michael Calcagni
Medrxiv. 2024-08-17 - 9 citationsAn ANXA11 P93S variant dysregulates TDP-43 and causes corticobasal syndrome.Allison Snyder, Veronica H Ryan, James Hawrot, Sydney Lawton, Daniel M Ramos
Alzheimer's & Dementia. 2024-08-01
Press Mentions
- ACTRIMS 2022: All Eyes on Neurofilament Light ChainMarch 7th, 2022
Smartphone-Based Symbol-Digit Modalities Test Reliably Captures Brain Damage in Multiple SclerosisFebruary 24th, 2021
Demystifying Medicine - Multiple Sclerosis: Advances in Pathogenesis and TreatmentFebruary 9th, 2021
Grant Support
- Comprehensive multimodal analysis of patients with neuroimmunological diseasesNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- From therapeutic mechanisms to unraveling the pathophysiology of MSNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
- From therapeutic mechanisms to unraveling the pathophysiology of MSNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent
